The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Postmenopausal hormones and incontinence: the heart and Estrogen/Progestin Replacement Study
Abstract
OBJECTIVE: To determine whether postmenopausal hormone therapy improves the severity of urinary incontinence. METHODS: We included measures of incontinence and voiding frequency in the Heart and Estrogen/Progestin Replacement Study, a randomized, blinded trial of the effect of hormone therapy among 2763 postmenopausal women younger than 80 years with coronary disease and intact uteri. This report includes 1525 participants who reported at least one episode of incontinence per week at baseline. Participants were randomly assigned to 0.625 mg of conjugated estrogens plus 2.5 mg of medroxyprogesterone acetate in one tablet daily (n = 768) or placebo (n = 757) and were followed for a mean of 4.1 years. Severity of incontinence was classified as improved (decrease of at least two episodes per week), unchanged (change of at most one episode per week), or worsened (increase of at least two episodes per week). RESULTS: Incontinence improved in 26% of the women assigned to placebo compared with 21% assigned to hormones, while 27% of the placebo group worsened compared with 39% of the hormone group (P =.001). This difference was evident by 4 months of treatment and was observed for both urge and stress incontinence. The number of incontinent episodes per week increased an average of 0.7 in the hormone group and decreased by 0.1 in the placebo group (P <.001). CONCLUSION: Daily oral estrogen plus progestin therapy was associated with worsening urinary incontinence in older postmenopausal women with weekly incontinence. We do not recommend this therapy for the treatment of incontinence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
Prevalence of Urinary Incontinence and Other Urological Symptoms in the Noninstitutionalized Elderly
Diokno, A. C., Brock, B. M., Brown, M. B., & Herzog, A. R. (1986) · Journal of Urology · doi:10.1016/s0022-5347(17)45194-9 · Cited by 738
Estrogen receptors in the human female lower urinary tract
Iosif, C. S., Batra, S. C., Ek, A., & Åstedt, B. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90710-9 · Cited by 383
Urinary incontinence in older women: Who is at risk?
BROWN, J., SEELEY, D., FONG, J., BLACK, D., ENSRUD, K., & GRADY, D. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00013-0 · Cited by 353
Self-citationFantl, J. A., Cardozo, L., & McClish, D. K. (1994) · PubMed · Cited by 337
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Self-citationEfficacy of estrogen supplementation in the treatment of urinary incontinence
ANDREWFANTL, J., BUMP, R., ROBINSON, D., MCCLISH, D., & WYMAN, J. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00281-5 · Cited by 230
Cited by
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Metadata
- Authors
- Grady, D.
- Venue
- Obstetrics & Gynecology
- Published
- 2001-01
- Volume
- 97
- Issue
- 1
- Pages
- 116-120
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2106025823
- Cited by
- 364
- References
- 18
- FWCI
- 13.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postmenopausal hormones and incontinence: the heart and Estrogen/Progestin Replacement Study. https://app.cochat.ai/papers/10.1016/s0029-7844(00)01115-7
- The paper
- Grady, D. (2001). Postmenopausal hormones and incontinence: the heart and Estrogen/Progestin Replacement Study. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(00)01115-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.